The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes - PubMed (original) (raw)
The use of phage display to distinguish insulin autoantibody (IAA) from insulin antibody (IA) idiotypes
D Devendra et al. Diabetologia. 2003 Jun.
Abstract
Aim/hypothesis: Radiobinding assays (RBA) are unable to differentiate insulin autoantibodies (IAA) from insulin antibodies (IA). We sought to establish whether random peptide phage display might generate reagents with which to distinguish IAA idiotopes from IA idiotopes.
Methods: Two insulin-binding sera were used to select phagotopes from a phage library. The first, designated IAS, came from an insulin-treated patient with the insulin autoimmune syndrome, and was known to contain both IA and a high titre of human insulin specific (B30 threonine dependent) IAA. The second, designated IDD, was taken from a newly-diagnosed IAA(+) Type 1 diabetic patient. Phage colonies selected by insulin-purified IgG extracts of IAS and IDD were selected at random for DNA sequencing, and tested for their reactivity with insulin antibodies and ability to distinguish disease-associated idiotopes.
Results: Seven phagotopes bound IAS and the phagotope designated IAS-9, corresponding to sequence KRSRLDV, gave the highest binding standard deviation (SD) score. Seven phagotopes bound IDD and the phagotope designated IDD-10, corresponding to sequence LGRGGSK, bound most strongly. IAS-9 was able to displace insulin binding in IAS and all of ten insulin-treated Type 2 diabetic patients, but not the IAA present in any of the eight patients with newly-diagnosed Type 1 diabetes. IDD-10, on the other hand, could displace insulin binding detected in the sera of eight patients with untreated Type 1 diabetes (IAA), but not in IAS or sera of the insulin-treated Type 2 diabetics.
Conclusion: Phagotopes provide reagents which between them can distinguish positively as well as negatively diabetes-associated IAA from non-diabetes associated IAA and from IA.
Similar articles
- Exploring the idiotypes of insulin antibodies as markers for remission in Type 1 diabetes.
Devendra D, Galloway TS, Horton SJ, Wilkin TJ. Devendra D, et al. Diabet Med. 2004 Dec;21(12):1316-24. doi: 10.1111/j.1464-5491.2004.01344.x. Diabet Med. 2004. PMID: 15569135 - Distinct idiotypes of insulin autoantibody in autoimmune polyendocrine syndrome type 2 and childhood onset type 1 diabetes.
Devendra D, Franke B, Galloway TS, Horton SJ, Knip M, Wilkin TJ. Devendra D, et al. J Clin Endocrinol Metab. 2004 Oct;89(10):5266-70. doi: 10.1210/jc.2004-0489. J Clin Endocrinol Metab. 2004. PMID: 15472233 - Developments in the prediction of type 1 diabetes mellitus, with special reference to insulin autoantibodies.
Franke B, Galloway TS, Wilkin TJ. Franke B, et al. Diabetes Metab Res Rev. 2005 Sep-Oct;21(5):395-415. doi: 10.1002/dmrr.554. Diabetes Metab Res Rev. 2005. PMID: 15895384 Review. - [The measurement of insulin antibodies and insulin autoantibodies by enzyme-linked immunosorbent assay using recombinant human insulin antigen and its clinical application].
Ueno H, Nishiyama A, Akita M, Watanabe T, Fukumura Y, Nagashima K, Ushijima Y, Kobayashi I. Ueno H, et al. Nihon Naibunpi Gakkai Zasshi. 1994 Aug 20;70(6):585-96. doi: 10.1507/endocrine1927.70.6_585. Nihon Naibunpi Gakkai Zasshi. 1994. PMID: 7958108 Clinical Trial. Japanese. - The molecular specificity of insulin autoantibodies.
Potter KN, Wilkin TJ. Potter KN, et al. Diabetes Metab Res Rev. 2000 Sep-Oct;16(5):338-53. doi: 10.1002/1520-7560(2000)9999:9999<::aid-dmrr145>3.0.co;2-l. Diabetes Metab Res Rev. 2000. PMID: 11025558 Review.
Cited by
- Anti-Islet Autoantibodies in Type 1 Diabetes.
Kawasaki E. Kawasaki E. Int J Mol Sci. 2023 Jun 11;24(12):10012. doi: 10.3390/ijms241210012. Int J Mol Sci. 2023. PMID: 37373160 Free PMC article. Review. - The effects of anti-insulin antibodies and cross-reactivity with human recombinant insulin analogues in the E170 insulin immunometric assay.
Kim S, Yun YM, Hur M, Moon HW, Kim JQ. Kim S, et al. Korean J Lab Med. 2011 Jan;31(1):22-9. doi: 10.3343/kjlm.2011.31.1.22. Korean J Lab Med. 2011. PMID: 21239867 Free PMC article. Clinical Trial. - Distinct clinical and laboratory characteristics of latent autoimmune diabetes in adults in relation to type 1 and type 2 diabetes mellitus.
Pipi E, Marketou M, Tsirogianni A. Pipi E, et al. World J Diabetes. 2014 Aug 15;5(4):505-10. doi: 10.4239/wjd.v5.i4.505. World J Diabetes. 2014. PMID: 25126396 Free PMC article. Review. - Targeting Anti-Insulin B Cell Receptors Improves Receptor Editing in Type 1 Diabetes-Prone Mice.
Bonami RH, Thomas JW. Bonami RH, et al. J Immunol. 2015 Nov 15;195(10):4730-41. doi: 10.4049/jimmunol.1500438. Epub 2015 Oct 2. J Immunol. 2015. PMID: 26432895 Free PMC article. - HLA Alleles Associate with Insulin Autoimmune Syndrome.
Yao D, Jiang J, Zhou Q, Feng C, Chu J, Chen Z, Yang J, Xia J, Chen Y. Yao D, et al. Diabetes Metab Syndr Obes. 2024 Sep 16;17:3463-3475. doi: 10.2147/DMSO.S456466. eCollection 2024. Diabetes Metab Syndr Obes. 2024. PMID: 39309309 Free PMC article. Review.
References
- FEBS Lett. 1998 Aug 14;433(1-2):103-7 - PubMed
- Biochemistry. 1992 Dec 1;31(47):11940-51 - PubMed
- Diabetes. 1993 Aug;42(8):1202-9 - PubMed
- J Autoimmun. 2002 Mar;18(2):191-6 - PubMed
- Ann Med. 1997 Oct;29(5):405-12 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases